BIND Therapeutics

Is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.

Launch date

2006

Employees

Market cap

Net debt

-

Cambridge Massachusetts (HQ)

http://bindtherapeutics.com

https://www.linkedin.com/company/bind-therapeutics

Get premium to view all results

Date	Investors	Amount	Round
-	investor investor	$0.0	round
Oct 2011	N/A	$0.0	round
Feb 2012	investor	$0.0	round
Feb 2013	N/A	$0.0	round
Sep 2013	N/A	$0.0	round
Feb 2015	N/A	$0.0	round
Jul 2016	Pfizer	$40.0m	Acquisition
Total Funding		000k